Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.
Previous studies have shown that the small molecule iron transport inhibitor ferristatin (NSC30611) acts by down-regulating transferrin receptor-1 (TfR1) via receptor degradation. In this investigation, we show that another small molecule, ferristatin II (NSC8679), acts in a similar manner to degrad...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3720890?pdf=render |
| _version_ | 1830412081176772608 |
|---|---|
| author | Shaina L Byrne Peter D Buckett Jonghan Kim Flora Luo Jack Sanford Juxing Chen Caroline Enns Marianne Wessling-Resnick |
| author_facet | Shaina L Byrne Peter D Buckett Jonghan Kim Flora Luo Jack Sanford Juxing Chen Caroline Enns Marianne Wessling-Resnick |
| author_sort | Shaina L Byrne |
| collection | DOAJ |
| description | Previous studies have shown that the small molecule iron transport inhibitor ferristatin (NSC30611) acts by down-regulating transferrin receptor-1 (TfR1) via receptor degradation. In this investigation, we show that another small molecule, ferristatin II (NSC8679), acts in a similar manner to degrade the receptor through a nystatin-sensitive lipid raft pathway. Structural domains of the receptor necessary for interactions with the clathrin pathway do not appear to be necessary for ferristatin II induced degradation of TfR1. While TfR1 constitutively traffics through clathrin-mediated endocytosis, with or without ligand, the presence of Tf blocked ferristatin II induced degradation of TfR1. This effect of Tf was lost in a ligand binding receptor mutant G647A TfR1, suggesting that Tf binding to its receptor interferes with the drug's activity. Rats treated with ferristatin II have lower TfR1 in liver. These effects are associated with reduced intestinal (59)Fe uptake, lower serum iron and transferrin saturation, but no change in liver non-heme iron stores. The observed hypoferremia promoted by degradation of TfR1 by ferristatin II appears to be due to induced hepcidin gene expression. |
| first_indexed | 2024-12-20T20:01:15Z |
| format | Article |
| id | doaj.art-8ed5233297f24950aeca6ea3a927f360 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T20:01:15Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8ed5233297f24950aeca6ea3a927f3602022-12-21T19:28:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e7019910.1371/journal.pone.0070199Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.Shaina L ByrnePeter D BuckettJonghan KimFlora LuoJack SanfordJuxing ChenCaroline EnnsMarianne Wessling-ResnickPrevious studies have shown that the small molecule iron transport inhibitor ferristatin (NSC30611) acts by down-regulating transferrin receptor-1 (TfR1) via receptor degradation. In this investigation, we show that another small molecule, ferristatin II (NSC8679), acts in a similar manner to degrade the receptor through a nystatin-sensitive lipid raft pathway. Structural domains of the receptor necessary for interactions with the clathrin pathway do not appear to be necessary for ferristatin II induced degradation of TfR1. While TfR1 constitutively traffics through clathrin-mediated endocytosis, with or without ligand, the presence of Tf blocked ferristatin II induced degradation of TfR1. This effect of Tf was lost in a ligand binding receptor mutant G647A TfR1, suggesting that Tf binding to its receptor interferes with the drug's activity. Rats treated with ferristatin II have lower TfR1 in liver. These effects are associated with reduced intestinal (59)Fe uptake, lower serum iron and transferrin saturation, but no change in liver non-heme iron stores. The observed hypoferremia promoted by degradation of TfR1 by ferristatin II appears to be due to induced hepcidin gene expression.http://europepmc.org/articles/PMC3720890?pdf=render |
| spellingShingle | Shaina L Byrne Peter D Buckett Jonghan Kim Flora Luo Jack Sanford Juxing Chen Caroline Enns Marianne Wessling-Resnick Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. PLoS ONE |
| title | Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. |
| title_full | Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. |
| title_fullStr | Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. |
| title_full_unstemmed | Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. |
| title_short | Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo. |
| title_sort | ferristatin ii promotes degradation of transferrin receptor 1 in vitro and in vivo |
| url | http://europepmc.org/articles/PMC3720890?pdf=render |
| work_keys_str_mv | AT shainalbyrne ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT peterdbuckett ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT jonghankim ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT floraluo ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT jacksanford ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT juxingchen ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT carolineenns ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo AT mariannewesslingresnick ferristatiniipromotesdegradationoftransferrinreceptor1invitroandinvivo |